Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chubb
Johnson and Johnson
Boehringer Ingelheim
Fish and Richardson
Fuji
Dow
Accenture
Federal Trade Commission

Generated: May 24, 2018

DrugPatentWatch Database Preview

NEXTERONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Nexterone, and when can generic versions of Nexterone launch?

Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. There are two patents protecting this drug.

This drug has forty-five patent family members in twenty countries.

The generic ingredient in NEXTERONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
Drug patent expirations by year for NEXTERONE
Synonyms for NEXTERONE
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone hydrochloride
(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone;hydrochloride
(2-Butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone hydrochloride (1:1)
(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone hydrochloride
(2-Butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)methanone hydrochloride
{2-[4-(2-butyl-1-benzofuran-3-carbonyl)-2,6-diiodophenoxy]ethyl}diethylamine hydrochloride
19774-82-4
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone hydrochloride
2-Butyl-3-benzofuranyl 4-[(2-diethylamino)ethoxy] 3,5-diiodophenyl ketone, hydrochloride
2-Butyl-3-benzofuranyl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]-methanone hydrochloride
2-Butyl-3-benzofuryl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone hydrochloride
51087 N HCl
774A824
976728SY6Z
A 8423
AB0012080
AC-078
AC1L9AZ7
ACT02681
AK149490
AKOS015844018
Ambap19774-82-4
Amio-Aqueous
Amiodar
Amiodarone (hydrochloride)
Amiodarone HCL
Amiodarone hydrochloride
Amiodarone hydrochloride (JP17/USAN)
Amiodarone hydrochloride [JAN]
Amiodarone hydrochloride [USP:JAN]
Amiodarone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Amiodaronum hydrochloride
AN-6656
Ancaron
Ancaron (TN)
Angoron
API0001454
Atlansil
BBC/822
BC207085
BG0032
C25H30ClI2NO3
calcium channel (L type) blocker
CAS-19774-82-4
CC-24084
CCG-39607
CHEBI:2664
CHEMBL1083993
Cordarex
Cordarone (TN)
CPD000058296
CS-1371
D00636
DSSTox_CID_17185
DSSTox_GSID_37185
DSSTox_RID_79304
DTXSID7037185
EINECS 243-293-2
EU-0100122
FT-0083531
FT-0622300
HE072922
HMS1569A20
HSDB 6525
HY-14188
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl, hydrochloride
Ketone,5-diiodophenyl, hydrochloride
KS-5249
L 3428 labaz
LP00122
Methanone, (2-butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)-, hydrochloride (9CI)
Methanone,5-diiodophenyl]-, hydrochloride
MFCD00069204
Miodrone
MLS000028520
MLS001076313
MLS001424272
MLS002222247
MolPort-002-915-715
NC00423
NCGC00015096-12
NCGC00093613-01
NCGC00093613-02
NCGC00093613-03
NCGC00093613-04
NCGC00254295-01
NCGC00260807-01
NSC 85442
NSC-759560
NSC-85442
NSC759560
NSC85442
Opera_ID_568
Pacerone
Pharmakon1600-02300165
PM-101
Prestwick_707
Q-200626
Renodoron
Ritmocardyl
Rythmarone
s1979
SAM001246646
SCHEMBL41348
SK&F-33134-A
SKF 33134 A
SKF 33134-A
SMR000058296
SPECTRUM2300165
TL8001651
Tox21_113478
Tox21_300395
Tox21_500122
Trangorex
UNII-976728SY6Z
W-5062
WLN: T56 BOJ C4 DVR CI EI DO2N2&2 &GH
Z2210825534
ZX-AS005021

US Patents and Regulatory Information for NEXTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-001 Dec 24, 2008 AP RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-002 Nov 16, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-001 Dec 24, 2008 AP RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-002 Nov 16, 2010 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for NEXTERONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-001 Dec 24, 2008 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-001 Dec 24, 2008 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for NEXTERONE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,750,822 Sulfoalkyl ether cyclodextrin compositions ➤ Sign Up
8,410,077 Sulfoalkyl ether cyclodextrin compositions ➤ Sign Up
9,200,088 Sulfoalkyl ether cyclodextrin compositions ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Merck
US Department of Justice
Fish and Richardson
Healthtrust
QuintilesIMS
US Army
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.